mTOR as a central hub of nutrient signalling and cell growth
J Kim, KL Guan - Nature cell biology, 2019 - nature.com
The highly conserved protein kinase mechanistic target of rapamycin (mTOR; originally
known as mammalian target of rapamycin) is a central cell growth regulator connecting …
known as mammalian target of rapamycin) is a central cell growth regulator connecting …
Non-canonical mTORC1 signaling at the lysosome
G Napolitano, C Di Malta, A Ballabio - Trends in cell biology, 2022 - cell.com
The mechanistic target of rapamycin complex 1 (mTORC1) signaling hub integrates multiple
environmental cues to modulate cell growth and metabolism. Over the past decade …
environmental cues to modulate cell growth and metabolism. Over the past decade …
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity
C Guo, Z You, H Shi, Y Sun, X Du, G Palacios, C Guy… - Nature, 2023 - nature.com
Cancer cells evade T cell-mediated killing through tumour–immune interactions whose
mechanisms are not well understood,. Dendritic cells (DCs), especially type-1 conventional …
mechanisms are not well understood,. Dendritic cells (DCs), especially type-1 conventional …
Reprogramming tumour-associated macrophages to outcompete cancer cells
In metazoan organisms, cell competition acts as a quality control mechanism to eliminate
unfit cells in favour of their more robust neighbours,. This mechanism has the potential to be …
unfit cells in favour of their more robust neighbours,. This mechanism has the potential to be …
A substrate-specific mTORC1 pathway underlies Birt–Hogg–Dubé syndrome
G Napolitano, C Di Malta, A Esposito, MEG de Araujo… - Nature, 2020 - nature.com
The mechanistic target of rapamycin complex 1 (mTORC1) is a key metabolic hub that
controls the cellular response to environmental cues by exerting its kinase activity on …
controls the cellular response to environmental cues by exerting its kinase activity on …
Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) remain
without effective therapies. The mechanistic target of rapamycin complex 1 (mTORC1) …
without effective therapies. The mechanistic target of rapamycin complex 1 (mTORC1) …
Regulation of mTORC1 by amino acids
L Bar-Peled, DM Sabatini - Trends in cell biology, 2014 - cell.com
The mechanistic target of rapamycin complex I (mTORC1) is a central regulator of cellular
and organismal growth, and hyperactivation of this pathway is implicated in the …
and organismal growth, and hyperactivation of this pathway is implicated in the …
The metabolic basis of kidney cancer
WM Linehan, LS Schmidt, DR Crooks, D Wei… - Cancer Discovery, 2019 - AACR
Kidney cancer is not a single disease but represents several distinct types of cancer that
have defining histologies and genetic alterations and that follow different clinical courses …
have defining histologies and genetic alterations and that follow different clinical courses …
The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1
The mTORC1 kinase is a master growth regulator that senses numerous environmental
cues, including amino acids. The Rag GTPases interact with mTORC1 and signal amino …
cues, including amino acids. The Rag GTPases interact with mTORC1 and signal amino …
The genetic basis of kidney cancer: a metabolic disease
WM Linehan, R Srinivasan, LS Schmidt - Nature reviews urology, 2010 - nature.com
Kidney cancer is not a single disease but comprises a number of different types of cancer
that occur in the kidney, each caused by a different gene with a different histology and …
that occur in the kidney, each caused by a different gene with a different histology and …